// App-Quantinova.ai

: Plasma miR371 for the detection of viable germ cell tumor in testicular cancer patients with enlarging or post chemotherapy residual nodes.

Researchers

Presenter

  • Lucia Nappi

Principal Investigators

  • Marisa Thi

  • Bernhard J. Eigl

  • Kim N. Chi

  • Martin Gleave

  • Alan I. So

  • Daniel Khalaf

  • Peter C. Black

  • Craig R. Nichols

  • Christian K. Kollmannsberger

Medical Centers

  • Vancouver Prostate Centre and SWOG AYA, Prevention and Surveillance and SWOG YI Award, Vancouver, BC, Canada

  • Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada

  • British Columbia Cancer Agency, Vancouver, BC, Canada

  • BC Cancer Agency, Vancouver, BC, Canada

  • British Columbia Cancer Agency, Vancouver, BC, Canada

  • The University of British Columbia, Vancouver, BC, Canada

  • Testicular Cancer Commons, Portland, OR

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved